Trial Profile
Phase II., non randomized, open study: inoperable gall bladder or biliary tract EGFR expressing carcinoma treatment with Erbitux and 5-fluorouracil, epiadriamycin, mitomycin containing combination
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Aug 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Epirubicin; Fluorouracil; Mitomycin
- Indications Biliary cancer; Gallbladder cancer
- Focus Therapeutic Use
- 13 Aug 2015 New trial record